Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Roy, Denis-Claude  [Clear All Filters]
Journal Article
Hillhouse EE, Thiant S, Moutuou MM, Lombard-Vadnais F, Parat R, Delisle J-S, Ahmad I, Roy D-C, Guimond M, Roy J, et al. Double negative T cells levels correlate with chronic graft-versus-host disease severity. Biol Blood Marrow Transplant. 2018.
Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle J-S, Fleury I, Kiss T, Mollica L, Roy D-C, et al. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients. Biol Blood Marrow Transplant. 2019.
Lachance S, Bourguignon A, Boisjoly J-A, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle J-S, Fleury I, et al. Impact of Implementing a Bendamustine-based Conditioning Regimen on outcomes of Autologous Stem Cell Transplant in Lymphoma while Novel Cellular Therapies Emerge. Transplant Cell Ther. 2022.
Qiu F, Maehara A, Khoury REl, Généreux P, LaSalle L, Mintz GS, Noiseux N, Roy D-C, Gobeil F, Stevens L-M, et al. Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. Coron Artery Dis. 2015.
Cohen S, Bambace N, Ahmad I, Roy J, Tang X, Zhang M-J, Burns LJ, Barabé F, Bernard L, Delisle J-S, et al. Improved Outcomes of UM171-Expanded Cord Blood Transplantation Compared with Other Graft Sources: Real-World Evidence. Blood Adv. 2023.
Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, et al. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. 2013.
Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, et al. UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections. Biol Blood Marrow Transplant. 2020.